Oral APIs
Various
ApprovedCommercial
Key Facts
About ChemWerth
Established in 1982 by Peter Werth, ChemWerth is a family-owned, global leader in the generic API sector, offering end-to-end services from product development to commercial supply. The company leverages exclusive partnerships with over 30 manufacturing facilities across the U.S., Europe, India, and China, and boasts a track record of over 550 worldwide regulatory approvals. Its core value proposition is enabling customers to reach the market faster through integrated technical, analytical, and regulatory support, with a focus on complex molecules, oncologicals, and antibiotics.
View full company profileOther Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| New TCM Formula Registration | Universe Pharmaceuticals | Development |
| CBD/THC Oil Formulation | Avecho Biotechnology | Preclinical |
| Bag APIs | ChemWerth | Approved |
| Companion Diagnostics Development | Kiffik Biomedical | Pre-clinical |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Portfolio of 40+ products | Praxgen Pharmaceuticals | Development |
| Drug Repositioning Service | Biovista | Service |
| Custom Control Development | Anchor Molecular | Development/Commercial |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |
| Generic Medicinal Products Development | Basic Pharma | Commercial |